Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT01236456
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of CIDP according to the American Academy of Neurology clinical and electrophysiologic criteria
* Age \>18 but \< 75 years
* Modified Rankin Scale score of \>3 after two standard treatment regimens
* Patient must have a left ventricular ejection fraction of \>45%
* Serum Creatinine \<3mg/dL
* Willingness to participate in a clinical trial
Exclusion Criteria:
* Patients who are preterminal or moribund
* Patients with active malignancies
* Patients with chromosomal abnormalities or peripheral blood counts suggestive of myelodysplastic syndrome
* Patients with active bacterial or fungal infections requiring oral or intravenous antimicrobials are not eligible until resolution of the infection
* Pregnant women and breast-feeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01236456
Study Brief:
Protocol Section:
NCT01236456